RTW Biotech notes investee Evommune's USD150 million IPO raise
(Alliance News) - RTW Biotech Opportunities Ltd on Friday noted one of its private portfolio companies Evommune Inc raised USD150 million in its initial public offering. Read More
| Price | $1.79 on 07-11-2025 at 19:40:08 |
|---|---|
| Change | $-0.01 -0.56% |
| Buy | $1.805 |
| Sell | $1.795 |
| Last Trade: | Sell 7,015.00 at $1.79 |
| Day's Volume: | 544,594 |
| Last Close: | $1.79 |
| Open: | $1.81 |
| ISIN: | GG00BKTRRM22 |
| Day's Range | $1.79 - $1.825 |
| 52wk Range: | $1.08 - $1.825 |
| Market Capitalisation: | $585.73m |
| VWAP: | $1.803515 |
| Shares in Issue: | 327.22m |
Rtw Biotech (RTW) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 7,015 | $1.79 | Uncrossing Trade |
16:35:01 - 07-Nov-25 |
| Unknown* | 72,900 | $1.805 | Negotiated Trade |
16:26:18 - 07-Nov-25 |
| Buy* | 210 | $1.805 | Automatic Execution |
16:17:25 - 07-Nov-25 |
| Sell* | 1,734 | $1.795 | Automatic Execution |
16:15:35 - 07-Nov-25 |
| Sell* | 3,002 | $1.795 | Automatic Execution |
16:15:35 - 07-Nov-25 |
| Unknown* | 29,266 | $1.789705 | Ordinary Currency Conversion |
16:06:55 - 07-Nov-25 |
| Sell* | 5,000 | $1.795 | Ordinary |
15:44:40 - 07-Nov-25 |
| Unknown* | 5,000 | $1.795 | OTC Trade |
15:44:40 - 07-Nov-25 |
| Sell* | 5,000 | $1.80 | Automatic Execution |
15:38:02 - 07-Nov-25 |
| Unknown* | 4,500 | $1.80 | Ordinary |
15:31:28 - 07-Nov-25 |
Rtw Biotech (RTW) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 7th Nov 2025 7:00 am | RNS | Evommune announces $150 million IPO |
| 5th Nov 2025 10:00 am | RNS | Holding(s) in Company |
| 3rd Nov 2025 9:33 am | RNS | Total Voting Rights |
| 31st Oct 2025 7:00 am | RNS | Royalty Funding Agreement with Savara Inc. |
| 29th Oct 2025 7:00 am | RNS | Transaction in Own Shares |
| 27th Oct 2025 7:00 am | RNS | Novartis to acquire Avidity Biosciences |
| 20th Oct 2025 7:00 am | RNS | Capital Allocation Plan based on M&A successes |
| 15th Oct 2025 7:00 am | RNS | Kailera Therapeutics announces Series B financing |
| 14th Oct 2025 7:00 am | RNS | Monthly Valuation Update and Factsheet |
| 10th Oct 2025 7:00 am | RNS | Novo Nordisk to acquire Akero Therapeutics |